The FDA has recently approved a new weight loss drug named Zep bounds. In this article, we will explore the key aspects of this medication as shared by Dr. Freda.

Zep bounds is a once-weekly injectable medication. Participants in clinical studies reported an average weight loss of 48 pounds when using it at its highest dose.

You may be a candidate for Zep bounds if you have obesity with a BMI of 30 or greater. Additionally, individuals with a BMI of 27 or greater and at least one comorbid condition, such as high blood pressure, high cholesterol, or heart disease, might be approved for its use.

Zep bounds is also known as tepati, the same formulation found in the diabetes therapy Mangaro. Importantly, Zep bounds can be prescribed without a diabetes diagnosis.

While effective, Zep bounds may lead to side effects such as nausea, vomiting, diarrhea, constipation, and abdominal bloating. Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should avoid this treatment.

It is crucial that Zep bounds is administered under the careful supervision of a healthcare professional to ensure safety and efficacy.